Matches in Wikidata for { <http://www.wikidata.org/entity/Q92961291> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q92961291 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92961291 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92961291 description "scientific article published on 17 June 2019" @default.
- Q92961291 description "wetenschappelijk artikel" @default.
- Q92961291 description "наукова стаття, опублікована 17 червня 2019" @default.
- Q92961291 name "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 name "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 type Item @default.
- Q92961291 label "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 label "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 prefLabel "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 prefLabel "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 P1433 Q92961291-5F7919F3-99C8-405B-B47B-1F7095F82F95 @default.
- Q92961291 P1476 Q92961291-89897939-3BFB-4B72-8872-D0536B7EC956 @default.
- Q92961291 P2093 Q92961291-1E7CDB74-3300-4D91-8DD9-8A522B7B3B7B @default.
- Q92961291 P2093 Q92961291-436B2F5E-B911-44BC-8D28-F97E9D95565F @default.
- Q92961291 P2093 Q92961291-4C6DDF23-054B-4AD8-96FF-9027645274A5 @default.
- Q92961291 P2093 Q92961291-6989F2E5-66D1-4E51-B3A2-D75F8EE1935B @default.
- Q92961291 P2093 Q92961291-791C2556-EC77-4883-A455-FD0B844BE19A @default.
- Q92961291 P2093 Q92961291-96A7A63C-364F-4638-B294-0D2877265D33 @default.
- Q92961291 P2093 Q92961291-C560E906-7D83-4B0F-B14A-A2DC63A46B2A @default.
- Q92961291 P2093 Q92961291-E89DAB0C-852B-4840-A606-F091BCFFAAF1 @default.
- Q92961291 P304 Q92961291-188BEB6D-4A37-40DB-A21F-8A60B895EC08 @default.
- Q92961291 P31 Q92961291-D3DB150F-997B-446C-84FB-AFAB8C605F65 @default.
- Q92961291 P356 Q92961291-9DE31104-F713-4A00-BBC3-E5C658BB0E0E @default.
- Q92961291 P478 Q92961291-97009987-C26A-4BF8-BB44-E9A7151E9911 @default.
- Q92961291 P50 Q92961291-0511496C-BDBC-4052-901E-E8B6451A1283 @default.
- Q92961291 P577 Q92961291-95BD7D0B-EEFD-48F1-B670-BD74A236378B @default.
- Q92961291 P698 Q92961291-8092DE40-8435-4DC8-AB53-008C3C306041 @default.
- Q92961291 P921 Q92961291-058E7F90-89D3-4505-9014-7031A2315D45 @default.
- Q92961291 P356 J.LEUKRES.2019.106172 @default.
- Q92961291 P698 31229804 @default.
- Q92961291 P1433 Q15716445 @default.
- Q92961291 P1476 "Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma" @default.
- Q92961291 P2093 "Claudia E Paba-Prada" @default.
- Q92961291 P2093 "Jeffrey Zonder" @default.
- Q92961291 P2093 "John Frye" @default.
- Q92961291 P2093 "Kenneth H Shain" @default.
- Q92961291 P2093 "Parameswaran Hari" @default.
- Q92961291 P2093 "Peter M Voorhees" @default.
- Q92961291 P2093 "Ralph Boccia" @default.
- Q92961291 P2093 "Yu-Lin Chang" @default.
- Q92961291 P304 "106172" @default.
- Q92961291 P31 Q13442814 @default.
- Q92961291 P356 "10.1016/J.LEUKRES.2019.106172" @default.
- Q92961291 P478 "83" @default.
- Q92961291 P50 Q87734443 @default.
- Q92961291 P577 "2019-06-17T00:00:00Z" @default.
- Q92961291 P698 "31229804" @default.
- Q92961291 P921 Q422252 @default.